S-1 plus cisplatin with concurrent radiotherapy for stage III non-small cell lung cancer: A meta-analysis (PRISMA) of randomized control trials

INTRODUCTION: The present study aims to assess the efficacy and safety of S-1 plus cisplatin as concurrent chemoradiation (experimental group [EG]) compared with standard concurrent chemoradiation regimens (control group[CG]) in patients with local advanced non-small cell lung cancer. METHODS: The C...

Descripción completa

Detalles Bibliográficos
Autores principales: Qie, Shuai, Li, Yanhong, Shi, Hong-yun, Yuan, Lanhui, Zhang, Xi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320030/
https://www.ncbi.nlm.nih.gov/pubmed/30557998
http://dx.doi.org/10.1097/MD.0000000000013441

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320030/
https://www.ncbi.nlm.nih.gov/pubmed/30557998
http://dx.doi.org/10.1097/MD.0000000000013441

Ejemplares similares